SOP1812 is a naphthalene diimide (ND) derivative with anti-tumor activity. SOP1812 binds to quadruplex arrangements (G4s), and down-regulates several cancer gene pathways. SOP1812 shows great affinity to hTERT G4 and HuTel21 G4 with K D values of 4.9 and 28.4 nM, respectively. SOP1812 can be used for the research of cancer.
性状
Solid
体外研究(In Vitro)
SOP1812 (0-50 nM; 96 h) inhibits the proliferation of many cancer cells.SOP1812 (0-800 nM; 6-24 h) shows great affinity to hTERT G4 and HuTel21 G4.SOP1812 (40 nM; 6-24 h) affects Wnt/β-catenin, axon guidance, Hippo, MAPK and Rap1 pathways. has not independently confirmed the accuracy of these methods. They are for reference only.Cell Proliferation Assay
体内研究(In Vivo)
SOP1812 (1 mg/kg; i.v. once or twice per week for 28 days) shows anti-tumor activity in MIA PaCa-2 xenografts mice and KPC mice. has not independently confirmed the accuracy of these methods. They are for reference only.
Animal Model: Female
运输条件
Room temperature in continental US; may vary elsewhere.
储存方式
Powder -20°C 3 years;In solvent -80°C 6 months
参考文献
[1]. Ahmed AA, et al. Asymmetrically Substituted Quadruplex-Binding Naphthalene Diimide Showing Potent Activity in Pancreatic Cancer Models. ACS Med Chem Lett. 2020 Jul 16;11(8):1634-1644.
溶解度数据
In Vitro: DMSO : 200 mg/mL (252.53 mM; Need ultrasonic)配制储备液